Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 49, 2020 - Issue 3
Submit an article Journal homepage
238
Views
6
CrossRef citations to date
0
Altmetric
Letters

Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody

M HondaDepartment of Rheumatology, Shimane University Faculty of Medicine, Izumo, JapanCorrespondence[email protected]
View further author information
,
M MoriyamaDepartment of Rheumatology, Shimane University Faculty of Medicine, Izumo, JapanView further author information
,
M KondoDepartment of Rheumatology, Shimane University Faculty of Medicine, Izumo, JapanView further author information
,
S KumakuraDepartment of Medical Education and Research, Shimane University Faculty of Medicine, Izumo, JapanView further author information
,
Y SumitaDepartment of Rheumatology, Shimane University Faculty of Medicine, Izumo, JapanView further author information
&
Y MurakawaDepartment of Rheumatology, Shimane University Faculty of Medicine, Izumo, JapanView further author information
Pages 244-246 | Accepted 05 Aug 2019, Published online: 01 Oct 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

MH has received speaking fees from Asahi Kasei Pharma Corporation and Ono Pharmaceutical Co., Ltd. MM has received speaking fees from Mitsubishi-Tanabe Pharma Corporation and Janssen Pharmaceutical KK, and manuscript fees from Sanofi KK. MK has received speaking fees from Eisai Co. Ltd, Chugai Pharma Co. Ltd, Mitsubishi-Tanabe Pharma, Bristol-Myers Squibb, Janssen Pharma KK, Astellas Pharma Inc, Takeda Pharma Co., Nippon Kayaku Co. Ltd, Daiichi-Sankyo Co. Ltd, Asahi Kasei Pharma Co., and AbbVie Japan. SK and YS have no conflicts of interest. YM has received grants from Asahi Kasei Pharmaceutical Co. Ltd, Chugai Pharmaceutical Co. Ltd, Ono Pharmaceutical Co. Ltd, Daiichi-Sankyo Co. Ltd, Teijin Pharma Ltd, Eisai Co. Ltd, Nippon Kayaku Co. Ltd, and Mitsubishi-Tanabe Pharma Corporation, instructor fees from Asahi Kasei Pharmaceutical Co. Ltd, Kissei Pharmaceutical Co. Ltd, and Janssen Pharmaceutical KK Eisai Co. Ltd, and speaking fees from Ono Pharmaceutical Co. Ltd, Mitsubishi-Tanabe Pharma Corporation, Astellas Pharma Inc, UCB Japan Co. Ltd, Chugai Pharmaceutical Co. Ltd, AbbVie Japan, Daiichi-Sankyo Co. Ltd, AYUMI Pharmaceutical Corporation, Janssen Pharmaceutical KK, Takeda Pharmaceutical Co. Ltd, Sanofi KK, Teijin Pharma Ltd, Eli Lilly Japan KK, and Eisai Co. Ltd.

Additional information

Funding

 

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 171.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.